Clinical Trial Update: NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1 [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completed Phase 1/Phase 2 results for the NMRC-M3V-Ad-PfCA vaccine targeting Plasmodium falciparum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• NMRC-M3V-Ad-PfCA vaccine

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Plasmodium Falciparum | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-05-21